ATE468411T1 - Methode zur darstellung der replikation von hbv und zum testen der sensibilität von wirkstoffen - Google Patents

Methode zur darstellung der replikation von hbv und zum testen der sensibilität von wirkstoffen

Info

Publication number
ATE468411T1
ATE468411T1 AT03785637T AT03785637T ATE468411T1 AT E468411 T1 ATE468411 T1 AT E468411T1 AT 03785637 T AT03785637 T AT 03785637T AT 03785637 T AT03785637 T AT 03785637T AT E468411 T1 ATE468411 T1 AT E468411T1
Authority
AT
Austria
Prior art keywords
hbv
seq
primer
vector
pharmaceutical product
Prior art date
Application number
AT03785637T
Other languages
English (en)
Inventor
David Durantel
Sandra Durantel
Christian Trepo
Fabien Zoulim
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE468411T1 publication Critical patent/ATE468411T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03785637T 2002-09-27 2003-09-26 Methode zur darstellung der replikation von hbv und zum testen der sensibilität von wirkstoffen ATE468411T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20020356188 EP1403385A1 (de) 2002-09-27 2002-09-27 Methode zur Darstellung der Replikation von HBV und zum Testen der Sensibilität von Wirkstoffen
PCT/EP2003/012398 WO2004029301A2 (en) 2002-09-27 2003-09-26 Method for assaying replication of hbv and testing susceptibility to drugs

Publications (1)

Publication Number Publication Date
ATE468411T1 true ATE468411T1 (de) 2010-06-15

Family

ID=31970489

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03785637T ATE468411T1 (de) 2002-09-27 2003-09-26 Methode zur darstellung der replikation von hbv und zum testen der sensibilität von wirkstoffen

Country Status (9)

Country Link
US (1) US20060240405A1 (de)
EP (2) EP1403385A1 (de)
CN (1) CN100562586C (de)
AT (1) ATE468411T1 (de)
AU (1) AU2003294704A1 (de)
CA (1) CA2500188A1 (de)
DE (1) DE60332641D1 (de)
ES (1) ES2346203T3 (de)
WO (1) WO2004029301A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1696040A1 (de) * 2005-02-28 2006-08-30 Eurofins Viralliance, Inc. Verfahren zur Bestimmung des Genotypes und des Phenotypes von Hepatitis B Viren, die Resistenz gegen antivirale Moleküle zeigen
CN101004415B (zh) * 2007-01-16 2011-07-27 复旦大学附属华山医院 一种测定乙型肝炎病毒阿德福韦耐药变异的方法
CN103114153B (zh) * 2013-02-05 2015-09-02 西安交通大学医学院第一附属医院 一种鸭乙型肝炎病毒的荧光定量pcr检测方法及试剂
WO2015057919A1 (en) * 2013-10-18 2015-04-23 The Johns Hopkins University Transgenic hepatitis b virus (hbv): a new model of hbv infection identifies uqcr10 as a viral replication factor
JP2018502604A (ja) 2015-01-27 2018-02-01 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 組換えＨＢＶ ｃｃｃＤＮＡ、その作製方法およびその使用
CN105907891A (zh) * 2016-05-27 2016-08-31 北京旌准医疗科技有限公司 检测乙型肝炎患者血液中HBV PgRNA 的方法、试剂盒及其应用
CN106555013A (zh) * 2016-11-28 2017-04-05 北京旌准医疗科技有限公司 Hbv病毒的检测方法、试剂盒及其应用
CN106868045A (zh) * 2017-02-24 2017-06-20 重庆市科学技术研究院 乙型肝炎e抗原阴性小鼠模型的构建方法
EP4174181A1 (de) 2020-06-24 2023-05-03 Xiamen University Arzneimittel-screening-modell und verfahren zum targeting von hbv-cccdna
CN112725535B (zh) * 2021-02-03 2024-05-31 江苏安科华捷生物科技有限公司 同时检测全长与截短的HBV pgRNA荧光定量PCR试剂盒及其应用
CN114204358B (zh) * 2021-12-13 2022-10-28 西安交通大学 一种带有电容的家用直流插头插座及工作方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077192A (en) * 1988-10-25 1991-12-31 The General Hospital Corporation Method of detecting antigenic, nucleic acid-containing macromolecular entities
EP0787200B1 (de) * 1994-10-28 2005-04-20 The Trustees Of The University Of Pennsylvania Rekombinanter adenovirus und methoden zu dessen verwendung
US5723319A (en) * 1995-06-05 1998-03-03 Avid Therapeutics, Inc. Cultured cell line that inducibly expresses the hepatitis B virus genome, and uses thereof for screening antiviral substances
US5856459A (en) * 1995-06-06 1999-01-05 Hybridon, Inc. Oligonucleotides specific for hepatitis B virus
US5858671A (en) * 1996-11-01 1999-01-12 The University Of Iowa Research Foundation Iterative and regenerative DNA sequencing method
DE19822287C2 (de) * 1998-05-18 2003-04-24 Switch Biotech Ag Klonierungsvektor, seine Herstellung und Verwendung zur Analyse von mRNA Expressionsmuster
US6783940B2 (en) * 2001-10-31 2004-08-31 Applera Corporation Method of reducing non-specific amplification in PCR

Also Published As

Publication number Publication date
EP1403385A1 (de) 2004-03-31
WO2004029301A2 (en) 2004-04-08
WO2004029301A3 (en) 2005-02-24
DE60332641D1 (de) 2010-07-01
CN100562586C (zh) 2009-11-25
AU2003294704A1 (en) 2004-04-19
CN1701124A (zh) 2005-11-23
EP1543168B1 (de) 2010-05-19
ES2346203T3 (es) 2010-10-13
CA2500188A1 (en) 2004-04-08
EP1543168A2 (de) 2005-06-22
US20060240405A1 (en) 2006-10-26

Similar Documents

Publication Publication Date Title
CN105518135B (zh) CRISPR-Cas9特异性敲除猪CMAH基因的方法及用于特异性靶向CMAH基因的sgRNA
CN105518139B (zh) CRISPR-Cas9特异性敲除猪FGL2基因的方法及用于特异性靶向FGL2基因的sgRNA
CN105518138B (zh) CRISPR-Cas9特异性敲除猪GFRA1基因的方法及用于特异性靶向GFRA1基因的sgRNA
CN105518137B (zh) CRISPR-Cas9特异性敲除猪SALL1基因的方法及用于特异性靶向SALL1基因的sgRNA
CN105492608B (zh) CRISPR-Cas9特异性敲除猪PDX1基因的方法及用于特异性靶向PDX1基因的sgRNA
WO2017181107A2 (en) Modified cpf1 mrna, modified guide rna, and uses thereof
WO2016187904A1 (zh) CRISPR-Cas9特异性敲除猪CMAH基因的方法及用于特异性靶向CMAH基因的sgRNA
US20110189684A1 (en) Method for determining drug resistance mutations in any of the non-structural protein regions ns3 to ns5b of hepatitis c virus (hcv) for genotypes 1 to 6
ATE468411T1 (de) Methode zur darstellung der replikation von hbv und zum testen der sensibilität von wirkstoffen
Laor et al. Detection of FMDV RNA amplified by the polymerase chain reaction (PCR)
CN115058543B (zh) 一组鉴别Delta变异毒株和Omicron变异毒株的引物组和试剂盒
Kjær et al. Selection of functional 2A sequences within foot-and-mouth disease virus; requirements for the NPGP motif with a distinct codon bias
Oliviero et al. RNA polymerase III promoter elements enhance transcription of RNA polymerase II genes
Gustin et al. Characterization of the role of individual protein binding motifs within the hepatitis B virus enhancer I on X promoter activity using linker scanning mutagenesis
Bartholomae et al. Insertion site pattern: global approach by linear amplification-mediated PCR and mass sequencing
Nthangeni et al. Development of a versatile cassette for directional genome walking using cassette ligation-mediated PCR and its application in the cloning of complete lipolytic genes from Bacillus species
Wang et al. Molecular cloning and expression of the hepatitis delta virus genotype IIb genome
Truter et al. Identification of an upstream regulatory region essential for cell type-specific transcription of the pro-alpha 2 (V) collagen gene (COL5A2).
Aquino et al. Linear amplification followed by single primer polymerase chain reaction to amplify unknown DNA fragments: complete nucleotide sequence of Oropouche virus M RNA segment
Binder et al. Molecular characterization of mtDNA depleted and repleted NT2 cell lines
Rosnera et al. Evaluation of linked PCR-transcription amplification procedure for bean yellow mosaic virus detection in gladioli
US20160177407A1 (en) Method for determining drug resistance mutations in any of the non-structural protein regions ns3 to ns5b of hepatitis c virus (hcv) for genotypes 1 to 6
Markle et al. Functional analysis of the KCS-like element of the interferon-inducible RNA-specific adenosine deaminase ADAR1 promoter
Sugimoto et al. Relative roles of T7 RNA polymerase and gene 4 primase for the initiation of T7 phage DNA replication in vivo.
US20090220943A1 (en) Hcv genotyping and phenotyping

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties